Results 121 to 130 of about 1,541,674 (284)
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang +3 more
wiley +1 more source
Lana Alhalaseh,1,* Hala Makahleh,1,* Bashayer Al-Saleem,1,* Farah Al-Omran,1,* Birgitte Schoenmakers2,* 1Department of Family and Community Medicine, School of Medicine, The University of Jordan, Amman, Jordan; 2Department of Public ...
Alhalaseh L +4 more
doaj
Background Stroke is one of the leading causes of death in Brazil, as well as a major cause of disability in the population. Because of this, national surveys are highly relevant for understanding the impact and planning public policies.
Jussara Almeida de Oliveira Baggio +5 more
doaj +1 more source
Do age and functional dependence affect outcomes of simultaneous heart-kidney transplantation? [PDF]
Feng I +9 more
europepmc +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
Discussion to: Do age and functional dependence affect outcomes of simultaneous heart-kidney transplantation? [PDF]
Takeda K, Feng I, Pagani FD.
europepmc +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Yang Hu,1,* Lijun Zuo,1,* Yuesong Pan,2 Hongyi Yan,2 Yongjun Wang,1 Xingquan Zhao1 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, People’s Republic of China; 2National Clinical Research Center for
Hu Y +5 more
doaj

